Royalty Pharma plcRPRXNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank60
3Y CAGR-62.3%
5Y CAGR+1.7%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
-62.3%/yr
vs +143.8%/yr prior
5Y CAGR
+1.7%/yr
Recent deceleration
Acceleration
-206.1pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 21.65 | +63.4% |
| 2024 | 13.24 | +19.5% |
| 2023 | 11.08 | -97.3% |
| 2022 | 404.10 | +1415.0% |
| 2021 | 26.67 | +33.9% |
| 2020 | 19.92 | +196.9% |
| 2019 | 6.71 | -41.3% |
| 2018 | 11.44 | -12.2% |
| 2017 | 13.03 | -72.7% |
| 2016 | 47.73 | - |